Cytokine Signalling Forum
Rheumatology Author Dr Stanley Cohen: Fenebrutinib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:23
- Mas informaciones
Informações:
Sinopsis
Dr Stanley Cohen from Southwestern Medical School. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Stanley Cohen discusses a phase 2 trial of BTK inhibitor, fenebrutinib.
